Sydney - Global investment manager Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has launched its new Australian investment trust for wholesale investors. The trust, led by investment veteran Dr. Tom Hancock, will provide Australian investors with access to GMO’s flagship Quality Strategy which invests in some of what GMO considers to be the highest quality and most durable businesses globally.
“Over our 40 year history, GMO has learnt that investing in top Quality companies with durable business models, high returns on capital, and secular growth drivers tends to provide superior risk-adjusted returns to investors over the long run,” said Dr. Hancock.
“In today’s market environment, where great uncertainty is creating significant opportunities from price dislocations and volatility, we are pleased to be launching the GMO Quality Trust in Australia. We believe our balanced approach provides investors with exposure to Quality stocks on both the defensive and growth ends of the spectrum that can help to endure a long downturn while simultaneously being able to do well as the recovery begins,” Dr. Hancock added.
The GMO Quality Strategy, which has consistently outperformed its benchmark since inception, was launched in February 2004 and currently has $9.6bn USD in FuM. The Strategy is managed by the GMO Focused Equity team which uses a combination of fundamental and systematic processes to identify a high conviction and high-quality universe of companies.
The GMO Quality Trust joins GMO Australia’s existing suite of funds including two Systematic Global Macro strategies and an Emerging Market equities trust.
GMO is a global investment manager that brings together focused expertise within our investment teams, industry-leading research, and tailored client service to advance our clients’ goals. Privately owned and renowned for our conviction in a valuation-based, long-term investment philosophy, GMO has been a partner to institutions, family offices, wealth managers, and consultants for over 40 years. For more information, please visit www.gmo.com.